Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Repare Therapeutics Announces a Strategic Partnership Agreement With ONO Pharmaceutical Co., Ltd.

Thursday, January 31, 2019

Repare Therapeutics Inc a privately held precision oncology company pioneering synthetic lethality to develop novel therapeutics that target specific vulnerabilities of tumors in clearly defined patient populations announced today that it has entered...

Cannassure Therapeutics Announces Strategic Partnership With Cannika Holdings

Thursday, January 31, 2019

Cannassure Therapeutics announces its collaboration with Cannika Holdings an agritech incubator specializing in cannabis innovation Cannika will operate out of the Cannassure campus utilizing their many facilities that are designed to meet the highes...

WCG Partners with Prudentia Group to Enhance Drug Safety in Clinical Development

Wednesday, January 30, 2019

The WIRBCopernicus Groups WCG Clinical Services Division has partnered with Prudentia Group a leading provider of drug safety and pharmacovigilance consulting services to deliver a comprehensive solution to enhance the quality safety and regulatory c...

FACIT and Triphase Accelerator Announce New Partnership with Celgene for First-in-class WDR5 Leukemia Therapy

Wednesday, January 30, 2019

Triphase Accelerator together with its majority shareholder FACIT today announced a new strategic collaboration with Celgene for a firstinclass preclinical therapeutic targeting the WDR protein for the treatment of blood cancers including leukemia Tr...

Horizon Discovery and Rutgers University form exclusive partnership to develop next generation novel gene editing technology

Tuesday, January 29, 2019

Horizon Discovery Group plc a global leader in gene editing and gene modulation technologies today announces that it has entered into an exclusive strategic partnership with Rutgers The State University of New Jersey US to develop and commercialise a...

Purdue Pharma L.P. and Alivio Therapeutics Enter into Partnership to Advance ALV-107, a Non-Opioid Interstitial Cystitis/Bladder Pain Syndrome Treatment

Tuesday, January 29, 2019

Purdue Pharma LP Purdue and Alivio Therapeutics today announced that they have entered into a partnership to advance one of Alivios product candidates through clinical development with an option exercisable by Purdue to collaborate on a limited numbe...

Q BioMed Technology Partner Mannin Research Enters Into Collaboration With McMaster University for Glaucoma Drug Candidate MAN-01

Monday, January 28, 2019

Q BioMed Inc a biotechnology acceleration company announced today that its technology partner Mannin Research has initiated a collaboration with McMaster University of Ontario Canada The collaboration is focused on ophthalmic drug delivery and formul...

Olon SpA acquires Capua BioServices SpA

Monday, January 28, 2019

Olon SpA a global leader in pharmaceutical active substances API a company dedicated to manufacturing and development outsourcing CDMO and a supplier of generics today announced the acquisition of Capua BioServices SpA a global supplier of CDMO serv...

BioNTech to Acquire Antibody Generation Unit of MAB Discovery

Friday, January 25, 2019

BioNTech AG a rapidly growing biotechnology company developing precise and individualized immunotherapies for the treatment of cancer and the prevention of infectious diseases and MAB Discovery GmbH a unique player in the generation and development o...

Origenis GmbH Announces Global License and Collaboration Agreement with Expansion Therapeutics for Novel Therapies Targeting RNA-mediated Diseases

Friday, January 25, 2019

Origenis announced today it has entered into a global license and collaboration agreement with Expansion Therapeutics to research and discover small molecule compounds targeting RNAmediated diseases As part of the agreement the companies will initiat...